Nachrichten zur Jazz Pharmaceuticals plc Aktie

Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation

…

Biotech-Einhorn! FDA Zulassung für das CBD-Wunder?!

Anzeige / WerbungEin einziges Medikament, das auf CBD basiert ist bislang von der FDA zur Verwendung zugelassen worden. Resultat: Der…

Earnings call: Jazz Pharmaceuticals reports robust 2023 financials By Investing.com

Earnings call: Jazz Pharmaceuticals reports robust 2023 financials…

Jazz Pharmaceuticals PLC (JAZZ) Q4 2023 Earnings Call Transcript

…

Jazz Pharmaceuticals plc 2023 Q4 - Results - Earnings Call Presentation

…

Jazz Pharmaceuticals names Philip Johnson as new CFO By Investing.com

Jazz Pharmaceuticals names Philip Johnson as new CFO…

AIM movers: Redx Pharma sells KRAS rights and claim by former Versarien boss

Redx Pharma (LON: REDX) is selling global rights to the preclinical-stage KRAS (Kirsten rat sarcoma virus) inhibitor programme to Jazz…

AIM movers: Redx Pharma sells KRAS rights and claim by former Versarien boss

Redx Pharma (LON: REDX) is selling global rights to the preclinical-stage KRAS (Kirsten rat sarcoma virus) inhibitor programme to Jazz…

Redx Pharma agrees sale of KRAS to Jazz Pharmaceuticals

Redx Pharma shares jumped on Wednesday after the group agreed on the disposal of their KRAS oncology inhibitor program. Jazz…

Redx Pharma agrees sale of KRAS to Jazz Pharmaceuticals

Redx Pharma shares jumped on Wednesday after the group agreed on the disposal of their KRAS oncology inhibitor program. Jazz…

Jazz Pharmaceuticals targets positive momentum in 2024, receives Outperform rating

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) received an Outperform rating and a target price of $160 from Baird, citing optimistic expectations for…

Jazz Pharmaceuticals: Aktie weiter in Bedrängnis.

Anzeige / WerbungUnsere letzte Kommentierung zur Aktie von Ende November überschrieben wir mit "Das hätte nicht passieren dürfen.".Unsere letzte Kommentierung…

Jazz Pharmaceuticals (JAZZ) PTSD Drug Misses Study Goals

After a mid-stage study fails to show any improvement in its primary or secondary endpoints, Jazz (JAZZ) plans to scrap…

Jazz Pharmaceuticals drops 4% as study of PTSD misses primary endpoint By Investing.com

Jazz Pharmaceuticals drops 4% as study of PTSD misses primary endpoint…

Jazz Pharmaceuticals Zanidatamab Promises Growth Amidst Market Undervaluation

…

Teva Pharma uniquely positioned, Jazz Pharmaceuticals set-up balanced

Teva Pharma uniquely positioned, Jazz Pharmaceuticals set-up balanced - UBS…

Jazz Pharmaceuticals plc 2023 Q3 - Results - Earnings Call Presentation

…

Jazz Pharmaceuticals exploring strategic options, including sale - Bloomberg

…

Lennox-Gastaut Syndrome Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Players to Watch Out - Zogenix, Epygenix, SK Life Science, Takeda, Jazz Pharmaceuticals, Longboard Pharmaceuticals

The dynamics of the Lennox-Gastaut syndrome market are anticipated to change in the coming years owing to the expected launch…

Jazz Pharmaceuticals: Droht hier ein Dammbruch?

Anzeige / WerbungVor dem Hintergrund der aktuellen Belastungsfaktoren gerät auch die Aktie des irischen Biotechnologieunternehmens Jazz Pharmaceuticals immer stärker unter…

Oligonucleotide API Market revenue to surpass USD 5 Billion by 2035, says Research Nester

Major Oligonucleotide API Market players include Ionis Pharmaceuticals, Inc., Jazz Pharmaceuticals plc, Biogen Inc., Sarepta Therapeutics, Alnylam Pharmaceuticals, Inc., Corden…

Psychedelic Drugs Market revenue to exceed USD 12 Billion by 2035, says Research Nester

Leading psychedelic drugs market players include Research Nester are COMPASS Pathways plc, Silo Pharma, Inc., Numinus Wellness Inc., Cybin Inc.,…

Insiderhandel: SVP, Chief Accounting Officer verkauft Aktien von Jazz Pharmaceuticals im Wert von 21.829$

Carr, Patricia - Vorstand - Tag der Transaktion: 2023-08-14...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Jazz Pharmaceuticals im Wert von 185.685$

Mcsharry, Heather Ann - Aufsichtsrat - Tag der Transaktion: 2023-08-14...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Jazz Pharmaceuticals im Wert von 171.455$

Winningham, Rick E. - Aufsichtsrat - Tag der Transaktion: 2023-08-14...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Jazz Pharmaceuticals im Wert von 171.454$

Smith, Mark Douglas - Aufsichtsrat - Tag der Transaktion: 2023-08-14...…

Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues?

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the…

Jazz Pharmaceuticals Non-GAAP EPS of $4.51 beats by $0.08, revenue of $957.32M beats by $15.16M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces Second Quarter 2023 Financial Results and Raises 2023 Full Year Financial Guidance

– Strong execution delivered second quarter 2023 total revenues of $957 million – – Commercial excellence drove continued adoption of…

Form 8-K Jazz Pharmaceuticals For: Aug 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is a Surprise Coming for Jazz Pharmaceuticals (JAZZ) This Earnings Season?

Jazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings…

The Zacks Analyst Blog Highlights Jazz Pharmaceuticals, Oshkosh and StoneCo

Jazz Pharmaceuticals, Oshkosh and StoneCo are part of the Zacks top Analyst Blog....…

Jazz Pharmaceuticals to Report 2023 Second Quarter Financial Results on August 9, 2023

DUBLIN, July 26, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 second…

Jazz Pharmaceuticals Gets CHMP Positive Opinion for JZP458

Jazz Pharmaceuticals Gets CHMP Positive Opinion for JZP458...…

Avadel Pharmaceuticals to Intervene in Jazz Pharmaceuticals Lawsuit Over FDA Ruling

Avadel Pharmaceuticals to Intervene in Jazz Pharmaceuticals Lawsuit Over FDA Ruling...…

Jazz Pharmaceuticals Files Complaint Against FDA for Decision on Avadel Pharmaceuticals Lumryz

Jazz Pharmaceuticals Files Complaint Against FDA for Decision on Avadel Pharmaceuticals' Lumryz...…

Jazz Pharma sues FDA over approval of Avadel narcolepsy drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Jazz Pharmaceuticals For: Jun 22

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: SVP, Chief Accounting Officer verkauft Aktien von Jazz Pharmaceuticals im Wert von 16.117$

Carr, Patricia - Vorstand - Tag der Transaktion: 2023-06-07...…

Insiderhandel: EVP & Chief Legal Officer verkauft Aktien von Jazz Pharmaceuticals im Wert von 204.763$

Patil, Neena M. - Vorstand - Tag der Transaktion: 2023-06-01...…

Jazz Pharmaceuticals Analysis Reveals THC And CBD Therapy Alleviates MS Spasticity

Treatment with the cannabis-based oral spray Nabiximols has been found to significantly relieve spasticity, a common symptom of multiple sclerosis (MS),…

Insiderhandel: EVP & Chief Financial Officer verkauft Aktien von Jazz Pharmaceuticals im Wert von 790.474$

Gala, Renee D. - Vorstand - Tag der Transaktion: 2023-05-18...…

Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates

Jazz (JAZZ) delivered earnings and revenue surprises of -7.28% and 0.59%, respectively, for the quarter ended March 2023. Do the…

Jazz Pharmaceuticals reaffirms 2023 guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q Jazz Pharmaceuticals For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jazz Pharmaceuticals Announces First Quarter 2023 Financial Results and Affirms 2023 Financial Guidance

Focus on commercial execution drove 1Q23 total revenues of $892.8 million Continued adoption of Xywav®; net product sales increased 49%…

Jazz Pharmaceuticals to Participate in the 2023 RBC Capital Markets Global Healthcare Conference

DUBLIN, May 2, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the…

Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023

DUBLIN, April 26, 2023 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 first…

Freedom Finance Börsenfrühstück - "Milliardenmarkt Krebsforschung und Krebstherapie"

Es sind erschreckende Zahlen: Eine halbe Million Menschen erkrankt in Deutschland jedes Jahr an Krebs. Meist beginnt damit ein Leidensweg…

Insiderhandel: EVP, GM of U.S., Commercial Ma verkauft Aktien von Jazz Pharmaceuticals im Wert von 421.044$

Sablich, Kim - Vorstand - Tag der Transaktion: 2023-03-08...…